VIR - Vir Biotechnology GAAP EPS of -$0.86 beats by $0.15 revenue of $16.79M beats by $10.24M
2024-02-22 16:27:48 ET
More on Vir Biotechnology
- Sticking With Vir Biotechnology
- JP Morgan cuts Vir to neutral, cites hepatitis drug franchise concerns
- Vir Biotechnology to shed 12% of workforce as part of corporate restructuring
- Seeking Alpha’s Quant Rating on Vir Biotechnology
- Historical earnings data for Vir Biotechnology